Correction of mexidol metabolic disorders in experimental pulmonary emphysema
Journal Title: Туберкульоз, легеневі хвороби, ВІЛ-інфекція - Year 2018, Vol 0, Issue 3
Abstract
Objective — to study the effectiveness of mexidol on the lipid peroxidation system/antioxidant protection in experimental pulmonary emphysema (PE). Materials and methods. The study is undertaken on 58 mature white rats weighing 180—200 g. The model of papainic emphysema in animals was reproduced by a single intratracheal injection under light ether anesthesia with 0,5 ml of papain solution at doses of 50 mg/kg, 75 mg/kg and 100 mg/kg of body weight. For 2 weeks after the administration of the papaini to animals, mexidol was administered at a dose of 25 mg/kg intramuscular every day. The amount of MDA and the activity of glutathione-dependent enzymes were determined. Results and discussion. Indices of the oxidant-antioxidant system in rat’s blood with experimental PE depending on the dose of papain and influence on them of mexidol were investigated. It was found that in 2 weeks after PE modeling at all doses of papain, there was a violation in the lipid peroxidation system/antioxidant protection: a significant increase in the amount of MDA in erythrocytes and a decrease in the activity of the main glutathione-dependent enzymes. It has been proven that the use of mexidol for therapeutic purposes, regardless of the dose of papain, leads to a decrease in the intensity of lipid peroxidation processes, an increase in the activity of GT, GR and GPO enzymes. Conclusions. The revealed metabolic disturbances in experimental PE are subject to correction by mexidol. Using of mexidol for therapeutic purposes helps to reduce the concentration of lipid peroxidation products, the activation of glutathione-dependent enzymes in the blood.
Authors and Affiliations
V. M. Zhadan, V. I. Korzhov
Keywords
Related Articles
- EP ID EP421397
- DOI 10.30978/TB2018-3-26
- Views 91
- Downloads 0
Clinical-morphological characteristics of surgical treatment of multidrug-resistant pulmonary tuberculosis in the last 10 years
Objective — to analyze the surgical activity in cases of pulmonary MDR-TB taking into account laboratory parameters over a 10-years period (based on the materials of a highly specialized NIFP clinic). Materials and metho...
Long-term results of surgical interventions for pulmonary tuberculosis
The results of surgical treatment of patients with pulmonary tuberculosis were evaluated depending on the prevalence of the tuberculosis process and the type of surgical intervention used. According to the results of the...
Current approaches of cough treatment, as the leading symptom of respiratory pathology
Objective — to assessment of the situation regarding the treatment of cough symptom in common diseases of the bronchopulmonary system in accordance with new guidelines and clinical guidelines. Materials and methods. Tes...
Correction of mexidol metabolic disorders in experimental pulmonary emphysema
Objective — to study the effectiveness of mexidol on the lipid peroxidation system/antioxidant protection in experimental pulmonary emphysema (PE). Materials and methods. The study is undertaken on 58 mature white rats w...
Improvement of endothelial function and external respiration in patients with comorbidity of hypertension and stage III chronic obstructive pulmonary disease, using nitric oxide donor — L-arginine
Objective — to improve the efficacy of pharmacotherapy for patients with comorbidity of arterial hypertension (AH) and stage III chronic obstructive pulmonary disease (COPD) (group C), using an exogenous nitric oxide don...